Found: 70
Select item for more details and to access through your institution.
Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapy.
- Published in:
- BJU International, 2005, v. 95, n. 9, p. 1336, doi. 10.1111/j.1464-410X.2005.05528.x
- By:
- Publication type:
- Article
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.
- Published in:
- BJU International, 2004, v. 94, n. 3, p. 412, doi. 10.1111/j.1464-410X.2004.04922.x
- By:
- Publication type:
- Article
Surgical Management of Intraabdominal Metastases From Melanoma: Role of the Neutrophil to Lymphocyte Ratio as a Potential Prognostic Factor.
- Published in:
- World Journal of Surgery, 2014, v. 38, n. 6, p. 1542, doi. 10.1007/s00268-013-2418-6
- By:
- Publication type:
- Article
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1392, doi. 10.3390/vaccines9121392
- By:
- Publication type:
- Article
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 13, p. 3991, doi. 10.1245/s10434-017-6072-3
- By:
- Publication type:
- Article
Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 5, p. 1048, doi. 10.1007/s10637-014-0063-z
- By:
- Publication type:
- Article
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12-13, 2017, Royal Society, London, UK.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2 γδ T cell cytotoxicity in a perforin-dependent manner.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 9, p. 1205, doi. 10.1007/s00262-017-2011-1
- By:
- Publication type:
- Article
Dendritic cell phenotype can be improved by certain chemotherapies and is associated with alterations to p21.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 10, p. 1553, doi. 10.1007/s00262-013-1456-0
- By:
- Publication type:
- Article
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1223, doi. 10.1007/s00262-013-1428-4
- By:
- Publication type:
- Article
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 4, p. 535, doi. 10.1007/s00262-011-1121-4
- By:
- Publication type:
- Article
Poly(I:C)-induced tumour cell death leads to DC maturation and Th1 activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1609, doi. 10.1007/s00262-011-1058-7
- By:
- Publication type:
- Article
Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 9, p. 1243, doi. 10.1007/s00262-011-1024-4
- By:
- Publication type:
- Article
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 7, p. 1033, doi. 10.1007/s00262-008-0620-4
- By:
- Publication type:
- Article
A prostate cancer vaccine comprising whole cells secreting IL-7, effective against subcutaneous challenge, requires local GM-CSF for intra-prostatic efficacy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 373, doi. 10.1007/s00262-008-0560-z
- By:
- Publication type:
- Article
The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 3, p. 277, doi. 10.1007/s00262-005-0061-2
- By:
- Publication type:
- Article
Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 4, p. 323, doi. 10.1007/s00262-003-0452-1
- By:
- Publication type:
- Article
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 521, doi. 10.1007/s00262-002-0309-z
- By:
- Publication type:
- Article
Immunotherapeutic potential of whole tumour cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 7, p. 351, doi. 10.1007/s00262-002-0286-2
- By:
- Publication type:
- Article
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
- Published in:
- Nature, 1989, v. 337, n. 6205, p. 368, doi. 10.1038/337368a0
- By:
- Publication type:
- Article
Variable and conserved neutralization antigens of human immunodeficiency virus.
- Published in:
- Nature, 1986, v. 324, n. 6097, p. 572, doi. 10.1038/324572a0
- By:
- Publication type:
- Article
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients.
- Published in:
- Nature, 1985, v. 316, n. 6023, p. 69, doi. 10.1038/316069a0
- By:
- Publication type:
- Article
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
- Published in:
- Nature, 1984, v. 312, n. 5996, p. 763, doi. 10.1038/312763a0
- By:
- Publication type:
- Article
Eosinophilic folliculitis occurring after bone marrow autograft in a patient with non-Hodgkin's lymphoma.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Infection, immunoregulation, and cancer.
- Published in:
- Immunological Reviews, 2011, v. 240, n. 1, p. 141, doi. 10.1111/j.1600-065X.2010.00987.x
- By:
- Publication type:
- Article
Releasing the restraints of Vγ9δd2 T-cells in cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1065495
- By:
- Publication type:
- Article
Characteristics and Growth Patterns of Human Peritoneal Mesothelial Cells: Comparison Between Advanced Epithelial Ovarian Cancer and Non-Ovarian Cancer Sources.
- Published in:
- Reproductive Sciences, 1999, v. 6, n. 6, p. 333, doi. 10.1177/107155769900600610
- By:
- Publication type:
- Article
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 6, p. 572, doi. 10.1038/sj.cgt.7700836
- By:
- Publication type:
- Article
Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.02059
- By:
- Publication type:
- Article
Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 4, p. 743, doi. 10.1002/ijc.22303
- By:
- Publication type:
- Article
Biomarkers for the Development of Cancer Vaccines.
- Published in:
- Molecular Diagnosis & Therapy, 2006, v. 10, n. 6, p. 337, doi. 10.1007/BF03256210
- By:
- Publication type:
- Article
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 3, p. 569, doi. 10.1007/s00280-010-1355-4
- By:
- Publication type:
- Article
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents.
- Published in:
- 2011
- By:
- Publication type:
- journal article
MTT assays can underestimate cell numbers.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Anticancer effects of phytocannabinoids used with chemotherapy in leukaemia cells can be improved by altering the sequence of their administration.
- Published in:
- International Journal of Oncology, 2017, v. 51, n. 1, p. 369, doi. 10.3892/ijo.2017.4022
- By:
- Publication type:
- Article
Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy.
- Published in:
- International Journal of Oncology, 2016, v. 49, n. 2, p. 793, doi. 10.3892/ijo.2016.3567
- By:
- Publication type:
- Article
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition.
- Published in:
- International Journal of Oncology, 2016, v. 48, n. 3, p. 908, doi. 10.3892/ijo.2016.3320
- By:
- Publication type:
- Article
Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.00809
- By:
- Publication type:
- Article
The gene expression profile of unstimulated dendritic cells can be used as a predictor of function.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 4, p. 979, doi. 10.1002/ijc.26101
- By:
- Publication type:
- Article
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 6, p. 1471, doi. 10.1002/ijc.25707
- By:
- Publication type:
- Article
The Power of the Web in Cancer Drug Discovery and Clinical Trial Design: Research without a Laboratory?
- Published in:
- Cancer Informatics, 2010, n. 8, p. 31
- By:
- Publication type:
- Article
The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for Vδ2<sup>+</sup>γδ T cells in the modulation of immune response to tumour?
- Published in:
- Immunology, 2020, v. 161, n. 3, p. 245, doi. 10.1111/imm.13248
- By:
- Publication type:
- Article
Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing.
- Published in:
- Immunology, 2014, v. 143, n. 4, p. 539, doi. 10.1111/imm.12331
- By:
- Publication type:
- Article
Enhanced cross-priming of naive CD8<sup>+</sup> T cells by dendritic cells treated by the IMi Ds<sup>®</sup> immunomodulatory compounds lenalidomide and pomalidomide.
- Published in:
- Immunology, 2013, v. 139, n. 3, p. 377, doi. 10.1111/imm.12087
- By:
- Publication type:
- Article
The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
- Published in:
- Apoptosis, 2012, v. 17, n. 2, p. 164, doi. 10.1007/s10495-011-0670-5
- By:
- Publication type:
- Article
The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients.
- Published in:
- Oncology Letters, 2022, v. 24, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13367
- By:
- Publication type:
- Article
The efficacy of chemotherapeutic drug combinations may be predicted by concordance of gene response to the single agents.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12184
- By:
- Publication type:
- Article